Selected Publications
Discovery
Rozenblatt-Rosen, Orit, Christina M. Hughes, Suraj J. Nannepaga, Kalai Selvi Shanmugam, Terry D. Copeland, Tad Guszczynski, James H. Resau, and Matthew Meyerson. 2005. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Molecular and Cellular Biology 25(2): 612–620.
Albright, Craig D., Philip M. Grimley, Raymond T. Jones, and James H. Resau. 2002. Differential effects of TPA and retinoic acid on cell-cell communication in human bronchial epithelial cells. Experimental and Molecular Pathology 72(1): 62–67.
Duesbery, N.S., J. Resau, C.P. Webb, S. Koochekpour, H.-M. Koo, S.H. Seppla, and G.F. Vande Woude. 2001. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proceedings of the National Academy of Sciences U.S.A. 98(7): 4089–4094.
Miura, Koichi, Shoko Miyazawa, Shuichi Furuta, Junji Mitsushita, Keiju Kamijo, Hiroshi Ishida, Toru Miki, Kazumi Suzukawa, James Resau, Terry D. Copeland, and Tohru Kamata. 2001. The Sos1-Rac1 signaling: possible involvement of a vacuolar H+-ATPase E subunit. Journal of Biological Chemistry 276(49): 46276–46283.
Image Analysis/Methods
Akervall, J., X. Guo, C.-N. Qian, J. Schoumans, B. Leeser, E. Kort, J. Yuhas, A. Cole, J. Resau, C. Bradford, T. Carey, H. Anderson, J. Tenvall, and B.T. Teh. 2004. Genetic expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clinical Cancer Research 10(24): 8204–8213.
Birchenall-Roberts, Maria C., Tao Fu, Ok-sun Bang, Michael Dambach, James H. Resau, Cari L. Sadowski, Daniel C. Bertolette, Ho-Jae Lee, Seong-Jin Kim, and Francis W. Ruscetti. 2004. Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. Journal of Biological Chemistry 279(24): 25605–25613.
Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, Beatrice S. Knudsen, Margaret F. Gustafson, Han-Mo Koo, George F. Vande Woude, and Milton D. Gross. 2003. Radioimmunoscintigraphy of human Met-expressing tumor xenografts using Met3, a new monoclonal antibody. Clinical Cancer Research 9(10): 3839S–3844S.
Bodart, Jean-François L., Davina V. Guiterrez, Angel R. Nebreda, Bree D. Buckner, James H. Resau, and Nicholas S. Duesbery. 2002. Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytes. Developmental Biology 245(2): 348–361.
Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude, and Milton D. Gross. 2002. Radioimmunoscintigraphy of tumors autocrine for human Met and hepatocyte growth factor/scatter factor. Molecular Imaging 1(1): 56–62.
Hay, Rick, Brian Cao, Ilan Tsarfaty, Galia Tsarfaty, James Resau, and George Vande Woude. 2002. Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use. Journal of Cellular Biochemistry S39: 184–193.
Miura, Koichi, Kerry M. Jacques, Stacey Stauffer, Atsutaka Kubosaki, Kejin Zhu, Dianne Snow Hirsch, James Resau, Yi Zheng, and Paul A. Randazzo. 2002. ARAP1: a point of convergence for Arf and Rho signaling. Molecular Cell 9(1): 109–119.
Qian, Chao-Nan, Xiang Guo, Brian Cao, Eric J. Kort, Chong-Chou Lee, Jindong Chen, Ling-Mei Wang, Wei-Yuan Mai, Hua-Qing Min, Ming-Huang Hong, George F. Vande Woude, James H. Resau, and Bin Tean Teh. 2002. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Research 62(2): 589–596.
Kino, Tomoshige, Roland H. Stauber, James H. Resau, George N. Pavlakis, and George P. Chrousos. 2001. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. Journal of Clinical Endocrinology and Metabolism 86(11): 5600–5608.
Pathology
Lengyel, Ernst, Dieter Prechtel, James H. Resau, Katja Gauger, Anita Welk, Kristina Lindemann, Georgia Salanti, Thomas Richter, Beatrice Knudsen, George F. Vande Woude, and Nadia Harbeck. 2005. c-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu. International Journal of Cancer 113(4): 678–682.
Holmen, Sheri L., Troy A. Giambernardi, Cassandra R. Zylstra, Bree D. Buckner-Berghuis, James H. Resau, J. Fred Hess, Vaida Glatt, Mary L. Bouxsein, Minrong Ai, Matthew L. Warman, and Bart O. Williams. 2004. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. Journal of Bone and Mineral Research 19(12): 2033–2040.
Tan, Min-Han, Carl Morrison, Pengfei Wang, Ximing Yang, Carola J. Haven, Chun Zhang, Maria S. Tretiakova, Eeva Korpi-Hyovalti, John R. Burgess, Khee Chee Soo, Wei-Keat Cheah, Brian Cao, James Resau, Hans Morreau, and Bin Tean Teh. 2004. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clinical Cancer Research 10: 6629–6637.
Kort, Eric J., Bryon Campbell, and James H. Resau. 2003. A human tissue and data resource: an overview of opportunities, challenges, and development of a provider/researcher partnership model. Computer Methods and Programs in Biomedicine 70(2): 137–150.
Quantification
Kort, Eric J., Ashley Jones, Michael Daumbach, Eric A. Hudson, Bree Buckner, and James H. Resau. 2003. Quantifying cell scattering: the blob algorithm revisited. Cytometry 51A(2): 119–126.
Altstock, Rom T., Gideon Y. Stein, James H. Resau, and Ilan Tsarfaty. 2000. Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in breast cancer: Met oncogene expression, and breast cancer as a model. Cytometry 41(3): 155–165.